| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10742396 | Journal of Geriatric Oncology | 2014 | 6 Pages |
Abstract
Elderly patients have a higher likelihood of not completing trials for reasons including toxicity. This highlights the need for better Phase I trial-designs incorporating ideal geriatric assessment tools.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Julie Rowe, Sukeshi Patel, Marcela Mazo-Canola, Alberto Parra, Martin Goros, Joel Michalek, Kevin Kelly, Steve Weitman, Anand Karnad,